Windtree Therapeutics Inc’s recently made public that its President and CEO Fraser Craig acquired Company’s shares for reported $4942.0 on Oct 08 ’24. In the deal valued at $0.91 per share,5,431 shares were bought. As a result of this transaction, Fraser Craig now holds 8,638 shares worth roughly $7774.2.
Ladenburg Thalmann initiated its Windtree Therapeutics Inc [WINT] rating to a Buy in a research note published on June 26, 2020; the price target was $12.25.
Price Performance Review of WINT
On Tuesday, Windtree Therapeutics Inc [NASDAQ:WINT] saw its stock fall -11.76% to $0.90. Over the last five days, the stock has lost -20.35%. Windtree Therapeutics Inc shares have fallen nearly -94.85% since the year began. Nevertheless, the stocks have fallen -99.58% over the past one year. While a 52-week high of $737.43 was reached on 01/02/25, a 52-week low of $0.95 was recorded on 05/06/25. SMA at 50 days reached $1.6551, while 200 days put it at $97.4188.
Levels Of Support And Resistance For WINT Stock
The 24-hour chart illustrates a support level at 0.8220, which if violated will result in even more drops to 0.7440. On the upside, there is a resistance level at 0.9840. A further resistance level may holdings at 1.0680. The Relative Strength Index (RSI) on the 14-day chart is 29.44, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1214, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 82.52%. Stochastics %K at 12.73% indicates the stock is a buying.
